Future studies to identify the specific receptor for Chm-1, and to determine the subsequent effect of signalling activation in a cell type dependent manner, are necessary to design therapeutic approaches for the treatment of Chm-1 related conditions, including osteoarthritis, infective endocarditis, and cancer. The gene discussed is CNMD; the disease is cancer.